APA (7th ed.) Citation

Zhiyi Lu & Fengyin Sun. (2022). Downregulated TICAM1 is a prognostic biomarker and associated with immune tolerance of Wilms tumor patients. BMC.

Chicago Style (17th ed.) Citation

Zhiyi Lu and Fengyin Sun. Downregulated TICAM1 Is a Prognostic Biomarker and Associated with Immune Tolerance of Wilms Tumor Patients. BMC, 2022.

MLA (9th ed.) Citation

Zhiyi Lu and Fengyin Sun. Downregulated TICAM1 Is a Prognostic Biomarker and Associated with Immune Tolerance of Wilms Tumor Patients. BMC, 2022.

Warning: These citations may not always be 100% accurate.